TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
GlaxoSmithKline Pharma A/S
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
63,663
|
59,207
|
59,959 |
| Earnings before taxes |
2,075
|
1,929
|
1,924 |
| Total assets |
15,742
|
15,573
|
18,489 |
| Current assets |
15,422
|
15,203
|
17,870 |
| Current liabilities |
10,658
|
10,576
|
13,720 |
| Equity capital |
5,084
|
4,968
|
4,677 |
| - share capital |
1,342
|
1,345
|
1,345 |
| Employees (average) |
75
|
75
|
75 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
32.3%
|
31.9%
|
25.3% |
| Turnover per employee |
849
|
789
|
799 |
| Profit as a percentage of turnover |
3.3%
|
3.3%
|
3.2% |
| Return on assets (ROA) | |||
| Current ratio |
144.7%
|
143.8%
|
130.2% |
| Return on equity (ROE) |
40.8%
|
38.8%
|
41.1% |
| Change turnover |
4,588
|
-752
|
561 |
| Change turnover % |
8%
|
-1%
|
1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.